Ahlers James M
Reporting Owner SEC Filing List
CIK: 0001320383
| Form | Filer | Subject Company | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 3 | Initial statement of beneficial ownershi... | Cue Biopharma, Inc. | 08/03/2026 | ||
| 3 | Initial statement of beneficial ownershi... | Ahlers James M | 08/03/2026 | ||
| 4 | Statement of changes in beneficial owner... | Cue Biopharma, Inc. | 08/03/2026 | ||
| 4 | Statement of changes in beneficial owner... | Ahlers James M | 08/03/2026 | ||
| 3 | Initial statement of beneficial ownershi... | Intensity Therapeutics, Inc. | Edgar Agents Llc /fa | 06/29/2023 | |
| 3 | Initial statement of beneficial ownershi... | Ahlers James M | Edgar Agents Llc /fa | 06/29/2023 | |
| 3 | Initial statement of beneficial ownershi... | Renovorx, Inc. | M2 Compliance /fa | 07/20/2022 | |
| 3 | Initial statement of beneficial ownershi... | Ahlers James M | M2 Compliance Llc /fa | 07/20/2022 | |
| 3 | Initial statement of beneficial ownershi... | Ahlers James M | Toppan Merrill /fa | 09/20/2005 | |
| 3 | Initial statement of beneficial ownershi... | Intarcia Therapeutics, Inc | Toppan Merrill/fa | 09/20/2005 |
Ahlers James M 's Ownership Transactions
| Issuer | Filing Date |
Transaction Date |
Transaction Type |
Shares | Price | Total Amt | Shares Owned |
|---|
